GlassScriptPhysician profile
Bedir Akbar
NPI 1962963264
$6,235.36
in general payments reported to CMS, 2019-2025
9 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $463 · 2022: $89.80 · 2024: $5,333 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,250 · Travel and Lodging: $1,811 · Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,250.00 |
| Travel and Lodging | $1,810.88 |
| Food and Beverage | $622.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,580.89 | 2024-2025 | |
| Medical Device Business Services, INC. | $305.00 | 2021 | |
| Davol INC. | $152.98 | 2021-2022 | |
| Csl Behring | $42.99 | 2021 | |
| Ferring Pharmaceuticals INC. | $42.42 | 2025 | Rebyota |
| Ethicon US, LLC | $38.25 | 2024-2025 | Stratafix, Endopath |
| Depuy Synthes Sales INC. | $33.65 | 2022 | |
| Teleflex LLC | $21.49 | 2024 | Quikclot |
| Janssen Pharmaceuticals, INC | $17.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bedir Akbar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.